Blood count, metabolic parameters (glucose, cholesterol, triglyceride, HbA1c, leptin, insulin), immune globuline levels (IgG, IgA, IgM), tumor markers (CEA, CA15.3), homocystein, TNF‐alpha, c‐peptide, IGF‐1, IGF‐1BP, sex hormone‐binding globulin, and hormone levels (FSH, LH, progesterone, testosterone, E2). The gene discussed is BRD2; the disease is neoplasm.